No Picture
Veritas Pharma Inc.

Veritas Pharma Enters Into Share Purchase Agreement with 3 Carbon Extractions Inc.

3 Carbon is in the business of designing cannabis extraction facilities and utilizing its own proprietary extraction methods. VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased […]

No Picture
Veritas Pharma Inc.

Veritas Pharma Closes Private Placement

VANCOUVER, British Columbia, March 29, 2018 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announces the closing of a private placement of units. Under the terms of the Private Placement Offering, […]

No Picture
Veritas Pharma Inc.

Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics

VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce the Company has completed the 100% takeover of its research arm, Cannevert Therapeutics Ltd. (“CTL”). As […]

No Picture
Veritas Pharma Inc.

Veritas Pharma Announces Appointment of Accomplished Business Development and Strategy Professional, Justin Kausel

VANCOUVER, British Columbia, March 15, 2018 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce that Justin Kausel has joined the Company as Director of Business Development. Justin will report to […]

No Picture
Veritas Pharma Inc.

Veritas Pharma Signs Letter of Intent with 3 Carbon Extractions Inc.

VANCOUVER, British Columbia, March 08, 2018 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce the signing of a non-binding Letter of Intent (“LOI”) with 3 Carbon Extractions Inc. (“Carbon”).  It […]

No Picture
Veritas Pharma Inc.

Veritas Intends to Complete the 100% Takeover of Cannevert Therapeutics in Q1

VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce the Company and its research arm, Cannevert Therapeutics Ltd. (“CTL”), are in process of obtaining […]

No Picture
Veritas Pharma Inc.

Veritas’ Research Arm Cannevert Signs Clinical Research Agreement for Human Studies to Assess its Lead Cannabis Strain for Pain

VANCOUVER, British Columbia, Jan. 10, 2018 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that its research arm, Cannevert Therapeutics Ltd. (“CTL”) has signed a clinical […]

No Picture
Veritas Pharma Inc.

Veritas Pharma Provides Year End Update on Company’s Activities to Shareholders

VANCOUVER, British Columbia, Jan. 04, 2018 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide an update to its prospective and current Veritas Shareholders regarding the Company’s activities and milestones […]